Wolverine Trading’s Ironwood Pharmaceuticals IRWD Stock Holding History

Wolverine Trading’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-12,502	Closed	-$54.8K	–	5264
2024 Q4	$54.8K	Sell	12,502 -245	-2%	-$994	﹤0.01%	4962
2024 Q3	$51.2K	Buy	+12,747	New	+$68.5K	﹤0.01%	4534
2024 Q2	–	Sell	-12,998	Closed	-$113K	–	4839
2024 Q1	$113K	Buy	+12,998	New	+$158K	﹤0.01%	4014
2021 Q4	–	Sell	-21,606	Closed	-$265K	–	6343
2021 Q3	$286K	Buy	21,606 +5,126	+31%	+$66.2K	﹤0.01%	4791
2021 Q2	$210K	Sell	16,480 -13,655	-45%	-$156K	﹤0.01%	4955
2021 Q1	$330K	Buy	30,135 +16,865	+127%	+$178K	﹤0.01%	4340
2020 Q4	$153K	Buy	13,270 +1,755	+15%	+$19.2K	﹤0.01%	4352
2020 Q3	$108K	Buy	11,515 +919	+9%	+$9.13K	﹤0.01%	4104
2020 Q2	$108K	Buy	+10,596	New	+$108K	﹤0.01%	4108
2019 Q1	–	Sell	-30,675	Closed	-$255K	–	4864
2018 Q4	$255K	Buy	+30,675	New	+$352K	﹤0.01%	3386
2017 Q4	–	Sell	-13,416	Closed	-$175K	–	5180
2017 Q3	$177K	Buy	+13,416	New	+$185K	﹤0.01%	3873

Other funds holding IRWD

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Wolverine Trading's IRWD Position: Q1 2025 in Review

Wolverine Trading sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2025, closing a stake of 12,502 shares — an estimated $54.8K sold.

Wolverine Trading first reported a position in IRWD in Q3 2017 and held it in 11 quarters. The position peaked at $330K in Q1 2021. 200 funds tracked by Wall St. Rank hold IRWD as of Q1 2025.

Wolverine Trading reported no remaining Ironwood Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
Wolverine Trading sold 12,502 Ironwood Pharmaceuticals shares in Q1 2025, an estimated $54.8K.
Wolverine Trading first reported a position in Ironwood Pharmaceuticals in Q3 2017 and held it in 11 quarters.
Wolverine Trading's Ironwood Pharmaceuticals position peaked at $330K in Q1 2021.
200 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2025.

Based on Wolverine Trading's 13F filing for Q1 2025, filed 15 May 2025.